Gladstone in the News
December 14, 2021
San Francisco Business Times—Senior Investigator Leor Weinberger, PhD, pioneered a new class of antivirals called therapeutic interfering particles (TIPs), which were recently shown to be effective against SARS-CoV-2 in animal models. The approach is now being developed by a startup company and will be headed to clinical trials.
Gladstone Experts
COVID-19
Center for Cell Circuitry
Virology
Weinberger Lab
Gladstone in the News
October 30, 2020
TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.
Gladstone Experts
HIV/AIDS
Center for Cell Circuitry
Virology
Weinberger Lab